Axogen Processing Center (APC) Opens in Vandalia
Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, opened its Axogen Processing Center (APC). The facility is designed to process Avance Nerve Graft®, a regenerative peripheral nerve scaffold indicated for the treatment of peripheral nerve functional deficit and used by surgeons across the U.S. and internationally to surgically repair injured nerves. The facility is located at 913 Industrial Park Dr. in Vandalia, Ohio.
Company Profile
Axogen (AXGN) is focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven, and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.
Axogen's platform for peripheral nerve repair features a comprehensive portfolio of products used across various applications and surgical specialties, including traumatic injuries, oral and maxillofacial surgery, breast reconstruction, and the surgical treatment of pain.
Business Need
The company wanted to establish a facility to expand their production capabilities and still have room for future growth.
Ohio Solution
APC is a world-class biologic processing center designed to provide expanded capacity and support the regulatory transition of Avance from a U.S Food and Drug Administration section 361 tissue product to a section 351 biologic. The 107,000 sq. ft. facility includes ISO14644 clean rooms, internal quality labs, a surgeon and tissue agency training lab, and state-of-the-art support systems and redundancies required for high-quality biologic processes. APC provides approximately three times the previous processing capacity and was designed for future growth and expansion. The facility currently employs nearly 100 professionals with plans to increase this number as production scales up.
“The development and validation of our Axogen Processing Center is a significant accomplishment for Axogen,” said Chairman, CEO and President Karen Zaderej. “This facility will meet the stringent standards needed for processing our industry-leading Avance Nerve Graft as a biologic and position us for significant future expansion and growth. We are pleased to have selected and constructed the facility in the Vandalia and the broader Dayton Ohio area where we have a strong team of talented engineers, quality professionals and technicians, dedicated to supporting patients with peripheral nerve injuries.”
Project Statistics
- Location: Vandalia
- Collaborators: Axogen, JobsOhio, Dayton Development Coalition, State of Ohio, City of Vandalia, Montgomery County
- Total capital investment: $11.3 million
- Jobs committed: 200
- Jobs retained: 28
